NDC 50090-0481-01 - Naproxen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-0481
- Requested NDC
- 50090-0481-01
- Package NDCs from labels
- 50090-0481-0, 50090-0481-7, 50090-0481-4, 50090-0481-5, 50090-0481-1, 50090-0481-9, 50090-0481-2, 50090-0481-6, 50090-0481-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-01-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naproxen - A-S Medication Solutions | A-S Medication Solutions | 2026-01-29 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-0481-0 | Naproxen | 15 in 1 BOTTLE | TABLET | 15 | 31 | |
| 50090-0481-1 | Naproxen | 20 in 1 BOTTLE | TABLET | 20 | 31 | |
| 50090-0481-2 | Naproxen | 30 in 1 BOTTLE | TABLET | 30 | 31 | |
| 50090-0481-4 | Naproxen | 14 in 1 BOTTLE | TABLET | 14 | 31 | |
| 50090-0481-5 | Naproxen | 40 in 1 BOTTLE | TABLET | 40 | 31 | |
| 50090-0481-6 | Naproxen | 100 in 1 BOTTLE | TABLET | 100 | 31 | |
| 50090-0481-7 | Naproxen | 60 in 1 BOTTLE | TABLET | 60 | 31 | |
| 50090-0481-9 | Naproxen | 6 in 1 BOTTLE | TABLET | 6 | 31 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-0481 | NAPROXEN TABLET [A-S MEDICATION SOLUTIONS] | 29 | Current NDC, Legacy NDC, 8 package rows | 20240905_000155a8-709c-44e5-a75f-cd890f3a7caf.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-0481-0 | EA - Each | 50090-0481 | b73d0457-aa5d-44d1-9ffe-8e84bc4b53d5 | 1 | 2018-09-05 |
| 50090-0481-1 | EA - Each | 50090-0481 | 8d86527d-2599-4a30-82a6-c2dbd1b98722 | 1 | 2018-09-05 |
| 50090-0481-2 | EA - Each | 50090-0481 | d92301e9-5ae9-43b2-b86b-e58dad9eaea9 | 1 | 2018-09-05 |
| 50090-0481-4 | EA - Each | 50090-0481 | 1442acf3-7793-4a96-8ebf-f200f2e60bce | 1 | 2018-09-05 |
| 50090-0481-5 | EA - Each | 50090-0481 | bac00d6f-6aa6-473b-a517-2d181646cda1 | 1 | 2018-09-05 |
| 50090-0481-6 | EA - Each | 50090-0481 | 3c8620e3-6f7e-46f4-a0de-5ad10fba1c21 | 1 | 2018-09-05 |
| 50090-0481-7 | EA - Each | 50090-0481 | 33b2100d-a17f-4f6d-bad0-120a73bada72 | 1 | 2018-09-05 |
| 50090-0481-9 | EA - Each | 50090-0481 | 08fbf0d0-348d-48a8-b1a1-760f87e60643 | 1 | 2018-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naproxen Sodium BACK AND MUSCLE PAIN | NAPROXEN SODIUM | Aurohealth LLC | c2066fce-cfa2-426d-ab6d-1a426736612b | 2025-05-23 | Warnings | 9TN87S3A3C |
| Naproxen Sodium | NAPROXEN SODIUM | WALMART INC. | 09b52dd4-0434-237c-e063-6294a90ab9b5 | 2025-05-23 | Warnings | 9TN87S3A3C |
| Naproxen Sodium | NAPROXEN SODIUM | CHAIN DRUG MARKETING ASSOCIATION, INC. | 04245a78-228e-439f-8ffb-9d9bc56c7bb7 | 2025-05-20 | Warnings | 9TN87S3A3C |
| NAPROXEN | NAPROXEN SODIUM | DISCOUNT DRUG MART | c1dce2e4-ad7a-4462-a775-9a5bcb2375ed | 2025-05-15 | Warnings | 9TN87S3A3C |
| NAPROXEN | NAPROXEN SODIUM | DISCOUNT DRUG MART | a0c67043-1e78-4eac-86e6-497b4364651a | 2025-05-15 | Warnings | 9TN87S3A3C |
| All Day Pain Relief | NAPROXEN SODIUM | Walmart Inc. | 32df7378-4dd1-4f7e-e063-6394a90ad948 | 2025-05-09 | Warnings | 9TN87S3A3C |
| Naproxen Sodium | NAPROXEN SODIUM | AAFES/Your Military Exchanges | c387f7cb-7cc4-4989-9f9a-bb00a895fd0d | 2025-05-08 | Warnings | 9TN87S3A3C |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b7eeeb-09ae-ffe6-e063-6294a90aba90 | 2025-05-07 | Warnings | 1K09F3G675 |
| Naproxen | NAPROXEN | A-S Medication Solutions | 7fef9311-471b-472c-b4f2-c952a2b3a255 | 2025-05-07 | Boxed warning, Warnings, Adverse reactions | 198014 57Y76R9ATQ |
| Naproxen | NAPROXEN | Camber Pharmaceuticals, Inc. | fd5e8d84-f92c-4f4b-ab0d-4cda7cf826bd | 2025-05-06 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| naproxen sodium | NAPROXEN SODIUM | Meijer Distribution Inc | 72f461bc-621e-4e2b-b437-53a580125f3c | 2025-05-02 | Warnings | 9TN87S3A3C |
| Leader All Day Sinus and Cold D | NAPROXEN SODIUM, PSEUDOEPHEDRINE HCL | Cardinal Health 110, LLC. dba Leader | 83f7cfbb-ab84-4594-ae7a-4a657385c8a7 | 2025-04-25 | Warnings | 9TN87S3A3C |
| All Day Sinus and Cold D | NAPROXEN SODIUM, PSEUDOEPHEDRINE HCL | Walgreen Company | b0417ce5-3a5e-42cb-8672-9f2b133c91ca | 2025-04-25 | Warnings | 9TN87S3A3C |
| Naproxen | NAPROXEN | Coupler LLC | 3375e139-d9de-8c2d-e063-6394a90a653d | 2025-04-23 | Boxed warning, Warnings, Adverse reactions | 198014 57Y76R9ATQ |
| Sinus and Cold D | NAPROXEN SODIUM, PSEUDOEPHEDRINE HCL | Meijer Distribution Inc | cb78330b-d8a3-4c16-bbb0-d31368a542e6 | 2025-04-18 | Warnings | 9TN87S3A3C |
| Topcare Sinus and Cold D | NAPROXEN SODIUM, PSEUDOEPHEDRINE HCL | Topco Associates LLC | 55c177ce-1729-4a9b-a5ae-2b6c96fbc27a | 2025-04-17 | Warnings | 9TN87S3A3C |
| Naproxen | NAPROXEN | A-S Medication Solutions | e63a034d-23ef-458f-88ed-8b6d73699621 | 2025-04-17 | Boxed warning, Warnings, Adverse reactions | ANDA078250 198013 57Y76R9ATQ |
| basic care naproxen sodium | NAPROXEN SODIUM | Amazon.com Services LLC | 29fc5a16-49ed-41ca-a296-bee34d1d12f6 | 2025-04-17 | Warnings | 9TN87S3A3C |
| Naproxen | NAPROXEN | Asclemed USA, Inc. | 1e406e47-408a-48cc-921e-52882a11581c | 2025-04-11 | Boxed warning, Warnings, Adverse reactions | 198014 57Y76R9ATQ |
| Aleve Caplets - Easy Open Arthritis Cap | NAPROXEN SODIUM | Bayer HealthCare LLC. | 94f09ef7-0695-4499-83c1-95f1e42baf98 | 2025-04-10 | Warnings | 9TN87S3A3C |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.